Celgene : CELG

All CELG Articles

433 Articles

Paul Ausick | May 21, 2018 at 4:04 PM EDT

Celgene, Campbell’s Soup Drop into Monday’s 52-Week Low Club

Celgene, Campbell's Soup, Banco Santander, and Teekay Tankers all posted new 52-week lows on Monday.

Paul Ausick | May 18, 2018 at 4:04 PM EDT

Campbell Soup, Celgene Stumble into Friday’s 52-Week Low Club

Campbell Soup, Cemex, Celgene, and Coty all posted new 52-week lows Friday.

Paul Ausick | May 17, 2018 at 4:04 PM EDT

Celgene, NetEase Drop into Thursday’s 52-Week Low Club

Celgene, NetEase, PPL Corp., and Vodafone all posted new 52-week lows Thursday.

Chris Lange | May 10, 2018 at 10:40 AM EDT

Big Biotechs Scare Off Short Sellers

The April 30 short interest data have been compared with the previous report, and short interest in most of the…

Paul Ausick | May 7, 2018 at 4:04 PM EDT

Tower Semiconductor, Celgene Drop into Monday’s 52-Week Low Club

Tower Semiconductor, Cemex, Celgene, and Sibanye Gold all posted new 52-week lows Monday.

Chris Lange | Apr 25, 2018 at 8:40 AM EDT

Major Biotechs Face Rising Tide of Short Interest

The April 13 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Apr 11, 2018 at 9:05 AM EDT

Short Sellers Back Way Off Major Biotechs

The March 29 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Apr 3, 2018 at 9:45 AM EDT

Celgene Shuffles the Deck: COO Steps Down Immediately

Celgene is shuffling the deck in terms of its executive leadership, and one of its top executives is stepping down.

Chris Lange | Mar 27, 2018 at 9:30 AM EDT

Major Biotechs See Rising Tide in Short Interest

The March 15 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Mar 21, 2018 at 9:45 AM EDT

Prothena Climbs on Celgene Collaboration

This collaboration with Celgene looks like a chance for Prothena to really shine, especially considering that it has had a…

Jon C. Ogg | Mar 21, 2018 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Applied Materials, Celgene, Children’s Place, Kinder Morgan, Match, Myriad Genetics, Nordstrom, Oracle and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Applied Materials, Celgene, Children's Place, Kinder Morgan, Match,…

Chris Lange | Mar 12, 2018 at 9:45 AM EDT

Major Biotechs: Tough Call for Short Sellers

The February 28 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Mar 8, 2018 at 11:50 AM EST

Merrill Lynch’s Top Biotech Acquisition Targets in 2018

Merrill Lynch has taken a look at the biotech industry and made a few picks that could play out in…

Paul Ausick | Feb 28, 2018 at 4:04 PM EST

Celgene, Weatherford Drop into Wednesday’s 52-Week Low Club

Celgene, Weatherford International, Akorn, and Cemex all posted new 52-week lows on Wednesday.

Chris Lange | Feb 28, 2018 at 1:15 PM EST

Why the Celgene Damage May Be an Overreaction

Celgene watched its shares drop on Wednesday after the company announced that it received a Refusal to File letter from…

1 … 3 4 5 6 7 … 29

Celgene : CELG

All CELG Articles

Celgene, Campbell’s Soup Drop into Monday’s 52-Week Low Club

Campbell Soup, Celgene Stumble into Friday’s 52-Week Low Club

Celgene, NetEase Drop into Thursday’s 52-Week Low Club

Big Biotechs Scare Off Short Sellers

Tower Semiconductor, Celgene Drop into Monday’s 52-Week Low Club

Major Biotechs Face Rising Tide of Short Interest

Short Sellers Back Way Off Major Biotechs

Celgene Shuffles the Deck: COO Steps Down Immediately

Major Biotechs See Rising Tide in Short Interest

Prothena Climbs on Celgene Collaboration

Top Analyst Upgrades and Downgrades: Applied Materials, Celgene, Children’s Place, Kinder Morgan, Match, Myriad Genetics, Nordstrom, Oracle and More

Major Biotechs: Tough Call for Short Sellers

Merrill Lynch’s Top Biotech Acquisition Targets in 2018

Celgene, Weatherford Drop into Wednesday’s 52-Week Low Club

Why the Celgene Damage May Be an Overreaction

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Celgene : CELG

All CELG Articles

Celgene, Campbell’s Soup Drop into Monday’s 52-Week Low Club

Campbell Soup, Celgene Stumble into Friday’s 52-Week Low Club

Celgene, NetEase Drop into Thursday’s 52-Week Low Club

Big Biotechs Scare Off Short Sellers

Tower Semiconductor, Celgene Drop into Monday’s 52-Week Low Club

Major Biotechs Face Rising Tide of Short Interest

Short Sellers Back Way Off Major Biotechs

Celgene Shuffles the Deck: COO Steps Down Immediately

Major Biotechs See Rising Tide in Short Interest

Prothena Climbs on Celgene Collaboration

Top Analyst Upgrades and Downgrades: Applied Materials, Celgene, Children’s Place, Kinder Morgan, Match, Myriad Genetics, Nordstrom, Oracle and More

Major Biotechs: Tough Call for Short Sellers

Merrill Lynch’s Top Biotech Acquisition Targets in 2018

Celgene, Weatherford Drop into Wednesday’s 52-Week Low Club

Why the Celgene Damage May Be an Overreaction

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do